金河生物：拟投资5000.00万元设立全资子公司

Core Viewpoint - The company plans to invest 50 million yuan to establish a wholly-owned subsidiary in Hohhot, Inner Mongolia, aimed at enhancing production capacity and resource allocation in the veterinary medicine and feed additive sectors [1] Group 1: Investment Details - The registered capital of the new subsidiary will be 50 million yuan, with a 100% ownership stake by the company [1] - The investment is intended to leverage the advantages of the company's Phase VI project and improve cost management and operational efficiency [1] Group 2: Strategic Alignment - This initiative aligns with the company's overall development strategy and aims to expand its business layout in veterinary medicine and feed additives [1] - The establishment of the subsidiary does not require shareholder approval and is not classified as a related party transaction or a major asset restructuring [1] Group 3: Risk Management - The new subsidiary is subject to the completion of business registration, which carries certain market and operational risks [1] - The company will enhance internal controls and risk prevention mechanisms to mitigate potential risks [1]